Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Eur J Hum Genet ; 8(10): 771-6, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11039577

ABSTRACT

Autosomal dominant hereditary spastic paraplegia (AD-HSP) is a genetically heterogeneous neurodegenerative disorder characterised by progressive spasticity of the lower limbs. The SPG4 locus at 2p21-p22 accounts for 40-50% of all AD-HSP families. The SPG4 gene was recently identified. It is ubiquitously expressed in adult and foetal tissues and encodes spastin, an ATPase of the AAA family. We have now identified four novel SPG4 mutations in German AD-HSP families, including one large family for which anticipation had been proposed. Mutations include one frame-shift and one missense mutation, both affecting the Walker motif B. Two further mutations affect two donor splice sites in introns 12 and 16, respectively. RT-PCR analysis of both donor splice site mutations revealed exon skipping and reduced stability of aberrantly spliced SPG4 mRNA. All mutations are predicted to cause loss of functional protein. In conclusion, we confirm in German families that SPG4 mutations cause AD-HSP. Our data suggest that SPG4 mutations exert their dominant effect not by gain of function but by haploinsufficiency. If a threshold level of spastin were critical for axonal preservation, such threshold dosage effects might explain the variable expressivity and incomplete penetrance of SPG4-linked AD-HSP.


Subject(s)
Adenosine Triphosphatases/genetics , Codon, Nonsense/genetics , Exons/genetics , Frameshift Mutation/genetics , Mutation, Missense , Spastic Paraplegia, Hereditary/genetics , Trinucleotide Repeats/genetics , Adenosine Triphosphatases/metabolism , DNA Primers/chemistry , Female , Genes, Dominant , Genotype , Humans , Male , Pedigree , Phenotype , Polymerase Chain Reaction , Polymorphism, Genetic , RNA Splicing/genetics , Restriction Mapping , Sequence Analysis, DNA , Spastin
2.
Hum Mol Genet ; 9(4): 637-44, 2000 Mar 01.
Article in English | MEDLINE | ID: mdl-10699187

ABSTRACT

Autosomal dominant hereditary spastic paraplegia (AD-HSP) is a group of genetically heterogeneous neurodegenerative disorders characterized by pro- gressive spasticity of the lower limbs. Five AD-HSP loci have been mapped to chromosomes 14q, 2p, 15q, 8q and 12q. The SPG4 locus at 2p21-p22 has been shown to account for approximately 40% of all AD-HSP families. SPG4 encoding spastin, a putative nuclear AAA protein, has recently been identified. Here, sequence analysis of the 17 exons of SPG4 in 87 unrelated AD-HSP patients has resulted in the detection of 34 novel mutations. These SPG4 mutations are scattered along the coding region of the gene and include all types of DNA modification including missense (28%), nonsense (15%) and splice site point (26.5%) mutations as well as deletions (23%) and insertions (7.5%). The clinical analysis of the 238 mutation carriers revealed a high proportion of both asymptomatic carriers (14/238) and patients unaware of symptoms (45/238), and permitted the redefinition of this frequent form of AD-HSP.


Subject(s)
Adenosine Triphosphatases/genetics , Genes, Dominant , Mutation , Paraplegia/genetics , Adenosine Triphosphatases/physiology , Adolescent , Adult , Aged , Child , Codon, Nonsense , Genotype , Humans , Middle Aged , Molecular Sequence Data , Mutation, Missense , Phenotype , Polymorphism, Genetic , RNA Splicing , Spastin
3.
Nat Genet ; 23(3): 296-303, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10610178

ABSTRACT

Autosomal dominant hereditary spastic paraplegia (AD-HSP) is a genetically heterogeneous neurodegenerative disorder characterized by progressive spasticity of the lower limbs. Among the four loci causing AD-HSP identified so far, the SPG4 locus at chromosome 2p2-1p22 has been shown to account for 40-50% of all AD-HSP families. Using a positional cloning strategy based on obtaining sequence of the entire SPG4 interval, we identified a candidate gene encoding a new member of the AAA protein family, which we named spastin. Sequence analysis of this gene in seven SPG4-linked pedigrees revealed several DNA modifications, including missense, nonsense and splice-site mutations. Both SPG4 and its mouse orthologue were shown to be expressed early and ubiquitously in fetal and adult tissues. The sequence homologies and putative subcellular localization of spastin suggest that this ATPase is involved in the assembly or function of nuclear protein complexes.


Subject(s)
Adenosine Triphosphatases/genetics , Mutation , Spastic Paraplegia, Hereditary/genetics , Adenosine Triphosphatases/chemistry , Adenosine Triphosphatases/metabolism , Amino Acid Motifs , Amino Acid Sequence , Animals , Base Sequence , Cells, Cultured , Cloning, Molecular , DNA Mutational Analysis , Exons/genetics , Expressed Sequence Tags , Humans , Introns/genetics , Mice , Mitochondria, Muscle/metabolism , Molecular Sequence Data , Oxidative Phosphorylation , RNA, Messenger/analysis , RNA, Messenger/genetics , Sequence Alignment , Sequence Homology, Amino Acid , Spastic Paraplegia, Hereditary/enzymology , Spastic Paraplegia, Hereditary/metabolism , Spastic Paraplegia, Hereditary/pathology , Spastin
4.
Genomics ; 60(3): 309-19, 1999 Sep 15.
Article in English | MEDLINE | ID: mdl-10493830

ABSTRACT

Autosomal dominant hereditary spastic paraplegia (AD-HSP) is a genetically heterogeneous disorder characterized by progressive spasticity of the lower limbs. A major locus (SPG4) causing AD-HSP in about 40% of the families was mapped to chromosome 2p. The analysis of six SPG4-linked AD-HSP families using the RED procedure previously showed the expansion of a CAG repeat in affected individuals. To identify the gene responsible for this form of HSP, we have constructed a 3.5-Mb YAC contig flanked by loci D2S400 and D2S367, have subcloned five of these YACs spanning the candidate region into cosmids, and screened these cosmid libraries for the presence of CAG repeat sequences. Four CAG repeats have been identified but none of them is expanded in 26 patients from 13 SPG4-linked AD-HSP families. A gene map comprising 21 transcripts was established using expressed sequence tags (ESTs) assigned previously to this region of 2p21-p22 with radiation hybrid panels GeneBridge 4 and G3. Full-length cDNAs corresponding to the 14 ESTs mapping to the SPG4 interval flanked by loci D2S352 and D2S2347 were isolated and sequenced. None contains a CAG repeat in its coding sequence. Finally, we have assembled a BAC contig composed of 37 clones that were also screened for the presence of CAG repeats; this failed to detect additional repeats to those identified on YACs.


Subject(s)
Chromosomes, Human, Pair 2/genetics , Spastic Paraplegia, Hereditary/genetics , Trinucleotide Repeats/genetics , Chromosomes, Bacterial/genetics , Cloning, Molecular , Contig Mapping , Expressed Sequence Tags , Humans , Microsatellite Repeats , Sequence Analysis, DNA
5.
Eur J Hum Genet ; 4(3): 127-34, 1996.
Article in English | MEDLINE | ID: mdl-8840112

ABSTRACT

Using in vitro amplification of cDNA by the polymerase chain reaction, we analyzed alternatively spliced events of cystic fibrosis transmembrane conductance regulator gene in lymphoblastoid cells. Ten alternatively spliced transcripts were identified using analysis of 6 overlapping segments of amplified cDNA, 4 of which have not been described previously. These include transcripts lacking exon 16, 17b, 22 and a transcript resulting from the use of a cryptic acceptor and donor splice sites. Moreover, in 2 cystic fibrosis (CF) patients bearing nonsense mutations E60X or W1282X, we observed that nonsense mutations are associated with an alteration of splice site selection in vivo resulting in exon skipping of constitutive exons or in the use of cryptic splice sites. In addition, even though lymphoblastoid cells are not the relevant tissue to address the question of the relationship between clinical respiratory phenotype and genotype, our results concerning adult CF patients (delta F508/ delta F508) suggest that individual-specific RNA splicing patterns could influence the severity of the CF pulmonary disease. If this phenomenon of alternative splicing events proves to be significant in CF and to be a common feature of disease genes, the study of RNA splicing could become an important tool for the analysis of the genotype-phenotype relationship in many inherited disorders.


Subject(s)
Alternative Splicing , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/genetics , Genes, Regulator , Lymphocytes/metabolism , RNA, Messenger/metabolism , Adult , Base Sequence , Chromosome Mapping , Humans , Molecular Sequence Data , Polymerase Chain Reaction
6.
Am J Hum Genet ; 56(3): 623-9, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7534040

ABSTRACT

mRNA analysis of the cystic fibrosis transmembrane regulator (CFTR) gene in tissues of cystic fibrosis (CF) patients has allowed us to detect a cryptic exon. The new exon involves 49 base pairs between exons 11 and 12 and is due to a point mutation (1811+1.6kbA-->G) that creates a new donor splice site in intron 11. Semiquantitative mRNA analysis showed that 1811+1.6kbA-->G-mRNA was 5-10-fold less abundant than delta F508 mRNA. Mutation 1811+1.6kbA-->G was found in 21 Spanish and 1 German CF chromosomes, making it the fourth-most-frequent mutation (2%) in the Spanish population. Individuals with genotype delta F508/1811+1.6kbA-->G have only 1%-3% of normal CFTR mRNA. This loss of 97% of normal CFTR mRNA must be responsible for the pancreatic insufficiency and for the severe CF phenotype in these patients.


Subject(s)
Cystic Fibrosis/genetics , Membrane Proteins/genetics , Point Mutation , RNA Splicing , Adolescent , Base Sequence , Child , Child, Preschool , Chromosome Mapping , Cystic Fibrosis Transmembrane Conductance Regulator , DNA/analysis , Exons , Genotype , Humans , Introns , Molecular Sequence Data , Phenotype , RNA/analysis
7.
Hum Genet ; 94(1): 65-8, 1994 Jul.
Article in English | MEDLINE | ID: mdl-7518409

ABSTRACT

Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR). Analysis of DNA from a pancreatic sufficient patient by means of denaturing gradient gel electrophoresis (DGGE) and subsequent DNA sequencing led to the identification of a novel potential splice mutation and a novel missense mutation in the CFTR gene. One C to T substitution (297-3C-->T) was found at the splice acceptor site of intron 2 and a T to C substitution at 1213 was found in exon 7. To determine the effect of the potential splicing mutation on the patient's CFTR transcripts and by taking advantage of the "illegitimate" transcription phenomenon, RNA from EBV-lymphoblastoid cells was reverse transcribed and amplified by the polymerase chain reaction (PCR). Direct sequencing of the PCR product revealed that the transcript from the chromosome with the 297-3C-->T mutation exhibited the skipping of exon 3.


Subject(s)
Cystic Fibrosis/genetics , Introns , Membrane Proteins/genetics , Point Mutation , RNA Splicing , Adult , Base Sequence , Cell Line, Transformed , Consensus Sequence , Cystic Fibrosis Transmembrane Conductance Regulator , DNA , DNA Mutational Analysis , Female , Humans , Molecular Sequence Data , Polymerase Chain Reaction , RNA, Messenger/genetics
12.
Hum Genet ; 88(5): 508-12, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1372586

ABSTRACT

Since the isolation of the cystic fibrosis transmembrane conductance regulator gene (CFTR) and the characterization of the main mutation (delta F508) in 1989, a large number of rare mutations has been found. Full screening of the CFTR gene is difficult because it is split into 27 exons covering 250 kb of genomic DNA. This gene is essentially expressed in the lung and intestinal tract, neither of which are easily accessible for routine investigations. The recent description of a faint transcription of highly tissue-specific genes in any cell, a phenomenon known as illegitimate transcription, would facilitate the research of mutations and the characterization of truncated m-RNA caused by splicing mutations. Using the polymerase chain reaction on cDNA (cDNA-PCR), we detected transcripts of the CFTR gene in lymphocytes and lymphoblast cells at a very low level (about 300 times less than in lung or intestine). This strategy allowed us to obtain a sufficient amount of cDNA-PCR product compatible with further molecular analyses. We have, therefore, analyzed a cDNA fragment overlapping exons 10 and 11 by polyacrylamide gel electrophoresis and direct sequencing, and detected the delta F508 mutation at this level. Our protocol can be generalized to the investigation of the total 4.5-kb CFTR coding sequence.


Subject(s)
Cystic Fibrosis/genetics , Lymphocytes/physiology , Membrane Proteins/genetics , Transcription, Genetic , Animals , Base Sequence , Cystic Fibrosis Transmembrane Conductance Regulator , DNA/genetics , DNA/isolation & purification , Exons , Humans , Liver/enzymology , Molecular Sequence Data , Oligodeoxyribonucleotides , Organ Specificity , Polymerase Chain Reaction/methods , Pyruvate Kinase/genetics , RNA, Messenger/genetics , RNA, Messenger/isolation & purification , Rats , Restriction Mapping
13.
C R Seances Soc Biol Fil ; 186(4): 371-6, 1992.
Article in French | MEDLINE | ID: mdl-1301225

ABSTRACT

In 1988, by using the powerful cDNA/PCR technique, it was demonstrated that there are very low levels of dystrophin mRNA in a variety of non-muscle tissues, including cultured fibroblasts and lymphoblastoid cell lines. The phenomenon was also shown for a number of other tissue-specific gene, including beta-globin, factors VIIIc and IX, anti-müllerian hormone, L-pyruvate kinase, retinal blue pigment, phenylalanine hydroxylase. The level of transcript in inappropriate cells is exceedingly low, perhaps one mRNA per 100-1,000 cells. This low-level ubiquitous transcription of tissue-specific genes was called "illegitimate" or "ectopic" transcription, and has been proven to occur for 17 gene transcripts to date. The mechanism and biological significance of illegitimate transcription are still obscure, but, since illegitimate transcripts exhibit the same pathology as legitimate transcripts, they have been useful tool in the study of already 9 inherited diseases. This strategy will be applied widely for diseases where samples from the appropriate tissue for study is difficult to obtain, or where an mRNA is easier or more informative to study than a genomic DNA (as for large genes, or where alternative splicings is involved).


Subject(s)
Molecular Biology , Transcription, Genetic , Humans , RNA, Messenger/analysis , RNA, Messenger/genetics
14.
Prenat Diagn ; 11(10): 787-98, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1800990

ABSTRACT

Three monoclonal antibodies (MAbs) against trophoblast (GB17, GB21, and GB25) and flow cytometry were used to sort trophoblast-like cells (TLCs) from peripheral blood of pregnant women. Sorted TLCs were processed for electron microscopy and fetal DNA amplification of the Y-specific sequences from mothers carrying male fetuses. At the ultra-structural level, most of the nucleated cells had the morphology of leucocytes, suggesting maternal contaminants, and we did not find the characteristic features of the free intervillous trophoblast cells. Nevertheless, polymerase chain reaction (PCR) analysis showed an amplification of Y-specific sequences in two out of three samples of sorted TLCs. These results suggest that besides the maternal leucocytes, sufficient trophoblast nucleated fetal cells can be obtained using cell enrichment by sorting. This sensitive method holds promise for non-invasive prenatal diagnosis of fetal sex and if sufficient Y(positive) nuclei are found, for the diagnosis of selected numerical chromosome abnormalities.


Subject(s)
Pregnancy/blood , Trophoblasts/immunology , Antibodies, Monoclonal , Blotting, Southern , Female , Flow Cytometry , Fluorescent Antibody Technique , Gestational Age , Humans , Microscopy, Electron , Polymerase Chain Reaction , Sex Determination Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...